View in EDS HTML Full Text PDF Full Text

ITGBL1 is a new immunomodulator that favors development of melanoma tumors by inhibiting natural killer cells cytotoxicity.

Saved in:
Bibliographic Details
Title: ITGBL1 is a new immunomodulator that favors development of melanoma tumors by inhibiting natural killer cells cytotoxicity.
Authors: Cheli Y; Université Nice Côte d'Azur, INSERM U1065, Team1 Biology and pathologies of melanocytes. Equipe labellisée ARC 2019, 06000, Nice, France. Yann.Cheli@univ-cotedazur.fr., Tulic MK; Université Nice Côte d'Azur, INSERM, U1065, Team12 Study of the melanocytic differentiation applied to vitiligo and melanoma, 06000, Nice, France., El Hachem N; Laboratory of Cancer Signaling, University of Liège, Liège, Belgium., Nottet N; Université Nice Côte d'Azur, INSERM U1065, Team1 Biology and pathologies of melanocytes. Equipe labellisée ARC 2019, 06000, Nice, France., Jacquel A; Université Nice Côte d'Azur, INSERM, U1065, Team2 Cell death, differentiation and cancer, 06000, Nice, France., Gesson M; Université Nice Côte d'Azur, INSERM, U1065, Imaging platform, 06000, Nice, France., Strub T; Université Nice Côte d'Azur, INSERM U1065, Team1 Biology and pathologies of melanocytes. Equipe labellisée ARC 2019, 06000, Nice, France., Bille K; Université Nice Côte d'Azur, INSERM U1065, Team1 Biology and pathologies of melanocytes. Equipe labellisée ARC 2019, 06000, Nice, France., Picard-Gauci A; CHU NICE, Département de Dermatologie, 06000, Nice, France., Montaudié H; CHU NICE, Département de Dermatologie, 06000, Nice, France., Beranger GE; Université Nice Côte d'Azur, INSERM U1065, Team1 Biology and pathologies of melanocytes. Equipe labellisée ARC 2019, 06000, Nice, France.; Université Nice Côte d'Azur, INSERM, U1065, Team12 Study of the melanocytic differentiation applied to vitiligo and melanoma, 06000, Nice, France., Passeron T; Université Nice Côte d'Azur, INSERM, U1065, Team12 Study of the melanocytic differentiation applied to vitiligo and melanoma, 06000, Nice, France.; CHU NICE, Département de Dermatologie, 06000, Nice, France., Close P; Laboratory of Cancer Signaling, University of Liège, Liège, Belgium., Bertolotto C; Université Nice Côte d'Azur, INSERM U1065, Team1 Biology and pathologies of melanocytes. Equipe labellisée ARC 2019, 06000, Nice, France., Ballotti R; Université Nice Côte d'Azur, INSERM U1065, Team1 Biology and pathologies of melanocytes. Equipe labellisée ARC 2019, 06000, Nice, France.
Source: Molecular cancer [Mol Cancer] 2021 Jan 07; Vol. 20 (1), pp. 12. Date of Electronic Publication: 2021 Jan 07.
Publication Type: Letter; Research Support, Non-U.S. Gov't
Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101147698 Publication Model: Electronic Cited Medium: Internet ISSN: 1476-4598 (Electronic) Linking ISSN: 14764598 NLM ISO Abbreviation: Mol Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 33413419
AccessLevel: 2
PubType: Report
PubTypeId: report
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: ITGBL1 is a new immunomodulator that favors development of melanoma tumors by inhibiting natural killer cells cytotoxicity.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Cheli+Y%22">Cheli Y</searchLink>; Université Nice Côte d'Azur, INSERM U1065, Team1 Biology and pathologies of melanocytes. Equipe labellisée ARC 2019, 06000, Nice, France. Yann.Cheli@univ-cotedazur.fr.<br /><searchLink fieldCode="AU" term="%22Tulic+MK%22">Tulic MK</searchLink>; Université Nice Côte d'Azur, INSERM, U1065, Team12 Study of the melanocytic differentiation applied to vitiligo and melanoma, 06000, Nice, France.<br /><searchLink fieldCode="AU" term="%22El+Hachem+N%22">El Hachem N</searchLink>; Laboratory of Cancer Signaling, University of Liège, Liège, Belgium.<br /><searchLink fieldCode="AU" term="%22Nottet+N%22">Nottet N</searchLink>; Université Nice Côte d'Azur, INSERM U1065, Team1 Biology and pathologies of melanocytes. Equipe labellisée ARC 2019, 06000, Nice, France.<br /><searchLink fieldCode="AU" term="%22Jacquel+A%22">Jacquel A</searchLink>; Université Nice Côte d'Azur, INSERM, U1065, Team2 Cell death, differentiation and cancer, 06000, Nice, France.<br /><searchLink fieldCode="AU" term="%22Gesson+M%22">Gesson M</searchLink>; Université Nice Côte d'Azur, INSERM, U1065, Imaging platform, 06000, Nice, France.<br /><searchLink fieldCode="AU" term="%22Strub+T%22">Strub T</searchLink>; Université Nice Côte d'Azur, INSERM U1065, Team1 Biology and pathologies of melanocytes. Equipe labellisée ARC 2019, 06000, Nice, France.<br /><searchLink fieldCode="AU" term="%22Bille+K%22">Bille K</searchLink>; Université Nice Côte d'Azur, INSERM U1065, Team1 Biology and pathologies of melanocytes. Equipe labellisée ARC 2019, 06000, Nice, France.<br /><searchLink fieldCode="AU" term="%22Picard-Gauci+A%22">Picard-Gauci A</searchLink>; CHU NICE, Département de Dermatologie, 06000, Nice, France.<br /><searchLink fieldCode="AU" term="%22Montaudié+H%22">Montaudié H</searchLink>; CHU NICE, Département de Dermatologie, 06000, Nice, France.<br /><searchLink fieldCode="AU" term="%22Beranger+GE%22">Beranger GE</searchLink>; Université Nice Côte d'Azur, INSERM U1065, Team1 Biology and pathologies of melanocytes. Equipe labellisée ARC 2019, 06000, Nice, France.; Université Nice Côte d'Azur, INSERM, U1065, Team12 Study of the melanocytic differentiation applied to vitiligo and melanoma, 06000, Nice, France.<br /><searchLink fieldCode="AU" term="%22Passeron+T%22">Passeron T</searchLink>; Université Nice Côte d'Azur, INSERM, U1065, Team12 Study of the melanocytic differentiation applied to vitiligo and melanoma, 06000, Nice, France.; CHU NICE, Département de Dermatologie, 06000, Nice, France.<br /><searchLink fieldCode="AU" term="%22Close+P%22">Close P</searchLink>; Laboratory of Cancer Signaling, University of Liège, Liège, Belgium.<br /><searchLink fieldCode="AU" term="%22Bertolotto+C%22">Bertolotto C</searchLink>; Université Nice Côte d'Azur, INSERM U1065, Team1 Biology and pathologies of melanocytes. Equipe labellisée ARC 2019, 06000, Nice, France.<br /><searchLink fieldCode="AU" term="%22Ballotti+R%22">Ballotti R</searchLink>; Université Nice Côte d'Azur, INSERM U1065, Team1 Biology and pathologies of melanocytes. Equipe labellisée ARC 2019, 06000, Nice, France.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101147698%22">Molecular cancer</searchLink> [Mol Cancer] 2021 Jan 07; Vol. 20 (1), pp. 12. <i>Date of Electronic Publication: </i>2021 Jan 07.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Letter; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BioMed+Central%22">BioMed Central </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101147698 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1476-4598 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214764598%22">14764598 </searchLink><i>NLM ISO Abbreviation: </i>Mol Cancer <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=33413419
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1186/s12943-020-01306-2
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 12
    Titles:
      – TitleFull: ITGBL1 is a new immunomodulator that favors development of melanoma tumors by inhibiting natural killer cells cytotoxicity.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Cheli Y
      – PersonEntity:
          Name:
            NameFull: Tulic MK
      – PersonEntity:
          Name:
            NameFull: El Hachem N
      – PersonEntity:
          Name:
            NameFull: Nottet N
      – PersonEntity:
          Name:
            NameFull: Jacquel A
      – PersonEntity:
          Name:
            NameFull: Gesson M
      – PersonEntity:
          Name:
            NameFull: Strub T
      – PersonEntity:
          Name:
            NameFull: Bille K
      – PersonEntity:
          Name:
            NameFull: Picard-Gauci A
      – PersonEntity:
          Name:
            NameFull: Montaudié H
      – PersonEntity:
          Name:
            NameFull: Beranger GE
      – PersonEntity:
          Name:
            NameFull: Passeron T
      – PersonEntity:
          Name:
            NameFull: Close P
      – PersonEntity:
          Name:
            NameFull: Bertolotto C
      – PersonEntity:
          Name:
            NameFull: Ballotti R
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 07
              M: 01
              Text: 2021 Jan 07
              Type: published
              Y: 2021
          Identifiers:
            – Type: issn-electronic
              Value: 1476-4598
          Numbering:
            – Type: volume
              Value: 20
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Molecular cancer
              Type: main
ResultId 1